about
Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?Response to "Health risks of genetically modified foods"Constraining cyclic peptides to mimic protein structure motifs.Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.Spontaneously formed monodisperse biomimetic unilamellar vesicles: the effect of charge, dilution, and time.Amphiphilic cholic-acid-modified dextran sulfate and its application for the controlled delivery of superoxide dismutase.Rapid intradermal delivery of liquid formulations using a hollow microstructured arrayPermeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system.Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor.Protein and peptide parenteral controlled delivery.In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids.Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method.Strategies to improve oral drug bioavailability.Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit modelEffect of polyols on the conformational stability and biological activity of a model protein lysozyme.Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.Antioxidative and antibacterial peptides derived from bovine milk proteins.Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats.Controlled delivery of bovine serum albumin from carboxymethyl xanthan microparticles.Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles.Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery.Poly(PEGDMA-MAA) copolymeric micro and nanoparticles for oral insulin deliveryPharmacokinetics and Half-Life of Protein Therapeutics
P2860
Q27023585-4EED79AD-4586-4370-A4DD-4D4C742AA6F2Q28269202-4B8FC01F-7A83-48F1-AD7D-009C22BE2FDEQ30367509-82EC9DFD-110F-4825-9B24-9FB55239CBB6Q30391507-EA7E145C-B054-4815-945A-C30A23248163Q33821550-C51A858C-362D-499D-A817-7E9E009B22E5Q34185424-D8439B8F-7328-449B-A4D5-82249F834264Q34274061-2BCC8491-4A5E-4FE5-B8CF-77CE35FD66ACQ34414561-5B36551F-7492-4EE0-BB89-CFE9C31AAA58Q34618222-C10E7C5D-1F81-432A-A67B-1E6F2D938738Q35605280-52AB0D91-6A10-4FF1-B0AA-AABDE20F5193Q35842593-969DCF41-6F3B-46D0-A377-B41A4799F0F2Q36137272-9FFA7BE4-E9C1-4928-B003-0B0B2DDE284CQ36177546-A595C2B5-DA08-41E9-B831-245C69D5A17BQ36316751-509D8312-21A6-4886-B536-08DE38A530A6Q36500104-E5D213A6-CFF2-4CBA-920E-2E5F836527AFQ36617821-DF246E7F-17FD-4A78-9A01-F83071766793Q37360954-BCCF8419-1132-468E-9101-21E1908AF61AQ38105259-AFBC8DC1-71B8-4877-827E-BECBF7F48E2BQ38936638-9E511FB0-D063-4421-9292-E8ABC6A419BDQ41365905-D021326E-60CC-42E0-8526-D406E062CCF4Q44720795-E59B6804-19FA-4064-ADA7-626154415577Q45948385-F97F68C5-6726-47B1-BDB6-1571AF5F32A0Q46262436-D1F8EA8D-FB56-4622-8FB1-F89387E81F6DQ53465156-C8D703F9-2B0D-4DC4-B44F-7CEB6F95EABFQ57342830-EFD5FCEB-00AD-4006-BC2D-C9995314C697Q58869604-2D376189-17CC-4E25-915D-5B0B8562DE0F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Protein drug oral delivery: the recent progress.
@ast
Protein drug oral delivery: the recent progress.
@en
Protein drug oral delivery: the recent progress.
@nl
type
label
Protein drug oral delivery: the recent progress.
@ast
Protein drug oral delivery: the recent progress.
@en
Protein drug oral delivery: the recent progress.
@nl
prefLabel
Protein drug oral delivery: the recent progress.
@ast
Protein drug oral delivery: the recent progress.
@en
Protein drug oral delivery: the recent progress.
@nl
P2860
P356
P1476
Protein drug oral delivery: the recent progress.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02976925
P577
2002-10-01T00:00:00Z
P6179
1001022621